Cancer News and Research

RSS

Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.

Study Identifies Enzymatic Regulation Mechanisms Involved in Tumor Survival and Resistance Pathways

Decoding of messenger RNA (mRNA) occurs during translation, the vital cellular process that builds proteins. Errors in this process are known to lead to cancer growth.

4 Nov 2026

Novel Molecular Bridge Links Coagulation Cascade with Cancer Hormonal Environment

New Cleveland Clinic research published in Cancer Cell shows that people with glioblastoma have more active platelets, which are cells involved in blood clotting. Platelets also communicate with other cells and can influence immune activity.

4 Nov 2026

Nanoparticle Displayed Antibody Fragments Ease Asthma Associated Goblet Cell Hyperplasia

Airway mucus is part of innate lung defense, but when production overwhelms clearance, it obstructs airflow and worsens disease.

4 Nov 2026

Innate Immune Sensor cGAS Acts as Nuclear Metabolic Regulator

Scientists at the University of North Carolina Lineberger Comprehensive Cancer Center have discovered an unexpected role for a key innate immune protein, revealing how it helps regulate cholesterol levels inside cells and influences tumor growth and treatment response.

4 Nov 2026

Microgravity Drives the Metabolic Switch From Glycolysis to Oxidative Phosphorylation

Earth-based hiPSC models have transformed disease research but remain limited by cellular immaturity, a strong reliance on glycolysis rather than oxidative phosphorylation (OXPHOS), and incomplete tissue architecture.

4 Nov 2026

Synthetic DNA Molecules Provide New Strategy for Targeting Cancer Linked Genes

Researchers have developed a promising new approach that uses synthetic DNA molecules to target cancer-linked genes directly, opening new possibilities for future treatments, diagnostics and biological research.

4 Nov 2026

Targeting CDK1 to Optimize Chemotherapy in Breast Cancer

Researchers at the Garvan Institute of Medical Research have found that the functioning of a protein known as CDK1 in breast cancer is associated with their reaction to a widely used treatment. This finding has the potential to guide more personalized treatment strategies for individuals.

3 Nov 2026

CRISPR Screen Uncovers COMPASS Pathway Role in Suppressing Gut Autoimmunity

Trillions of bacteria live in the human gut without triggering an immune response. Scientists at St. Jude Children's Research Hospital have now discovered a gene-regulatory pathway that helps maintain this delicate balance.

3 Nov 2026

Mitochondrial Iron Accumulation Drives Perforin Mediated Cancer Cell Death

For decades, scientists have known that a protein made by T cells and natural killer (NK) cells in the immune system, called perforin, can kill tumor cells by punching a hole in the cell wall and injecting proteases called granzymes, which kill the cell.

2 Nov 2026

UCLA Health Study Identifies Strategy to Boost Strength and Longevity of Cancer Fighting T Cells

Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have identified a promising new strategy to make cancer-fighting immune cells stronger and potentially longer-lasting, a discovery that could help improve the effectiveness of immunotherapies that use a patient's own immune cells to attack cancer.

31 Oct 2026

Novel Translational Mechanism Selectively Drives Growth Proteins in Common Cancers

A previously unknown mechanism helps cancer cells selectively produce proteins that drive tumor growth - such as KRAS - in common cancers, according to new research from The University of Texas MD Anderson Cancer Center.

30 Oct 2026

Cytosolic Glucose and Mitochondrial Lactate Oxidation Prevent Energetic Collapse

The heart is the hardest-working muscle in the body, beating constantly no matter what the body’s energy reserves look like.

30 Oct 2026

Aberrant RNA Splicing Generates Immunogenic Neoantigens in Systemic Lupus

Scientists at La Jolla Institute for Immunology (LJI) and the University of Washington (UW) have discovered that patients with lupus have unusual mutations that may turn their bodies into battlegrounds.

30 Oct 2026

“Izas, la princesa guisante” and Sant Joan de Déu Hospital Barcelona Launch an International Expert Tumor Board to Improve Care for Children with Gliomatosis Cerebri

The Spanish association “Izas, la princesa guisante” and the Pediatric Cancer Center Barcelona (PCCB) at Sant Joan de Déu Hospital have reached another milestone in the fight against childhood cancer: they have helped establish an international expert tumor board dedicated to pediatric gliomatosis cerebri.

28 Oct 2026

Lung Scarring Claims 11 Australian Lives Every Day: Landmark Report

A respiratory condition that leaves the lungs irreversibly scarred is claiming almost 4,000 Australian lives every year, with an alarming number of cases caused by workplace exposures in industries such as mining, farming and construction.

28 Oct 2026

Why a Breakthrough Blood Cancer Drug Could be Better for Patients

A more effective and better-tolerated treatment for chronic myeloid leukaemia (CML) could improve quality of life for people living with the disease.

27 Oct 2026

Researchers Develop Predictive Model for Mass Spectrometry Imaging

Andrei Fedorov and his team have found a way to take some of the guesswork out of mass spectrometry imaging (MSI), potentially giving scientists better tools to explore the molecules that influence our health.

27 Oct 2026

OGT Launches First Fusion MRD NGS Panel for AML to Expand Fusion Detection at MRD-Level Sensitivity

OGT, a leading global provider of genomic research and diagnostic solutions, today announced the launch of the SureSeq™ myPanel Myeloid Fusion MRD Panel, the first-to-market dedicated fusion MRD next-generation sequencing (NGS) panel for acute myeloid leukemia (AML).

27 Oct 2026

PARP1 Disassembles Nucleosomes to Facilitate Essential DNA Damage Repair

When DNA is damaged, cellular processes respond and repair the DNA. Inhibiting DNA damage repair can be therapeutically beneficial in cancers with genetic vulnerabilities related to DNA damage response.

26 Oct 2026

Squeezing Cell Nuclei Loosens DNA to Boost CRISPR Reprogramming Efficiency

Our cells hold about two meters of DNA, folded and compacted to fit inside a nucleus far narrower than a strand of human hair.

24 Oct 2026

Cancer News and Research

Study Identifies Enzymatic Regulation Mechanisms Involved in Tumor Survival and Resistance Pathways

Novel Molecular Bridge Links Coagulation Cascade with Cancer Hormonal Environment

Nanoparticle Displayed Antibody Fragments Ease Asthma Associated Goblet Cell Hyperplasia

Innate Immune Sensor cGAS Acts as Nuclear Metabolic Regulator

Microgravity Drives the Metabolic Switch From Glycolysis to Oxidative Phosphorylation

Synthetic DNA Molecules Provide New Strategy for Targeting Cancer Linked Genes

Targeting CDK1 to Optimize Chemotherapy in Breast Cancer

CRISPR Screen Uncovers COMPASS Pathway Role in Suppressing Gut Autoimmunity

Mitochondrial Iron Accumulation Drives Perforin Mediated Cancer Cell Death

UCLA Health Study Identifies Strategy to Boost Strength and Longevity of Cancer Fighting T Cells

Novel Translational Mechanism Selectively Drives Growth Proteins in Common Cancers

Cytosolic Glucose and Mitochondrial Lactate Oxidation Prevent Energetic Collapse

Aberrant RNA Splicing Generates Immunogenic Neoantigens in Systemic Lupus

“Izas, la princesa guisante” and Sant Joan de Déu Hospital Barcelona Launch an International Expert Tumor Board to Improve Care for Children with Gliomatosis Cerebri

Lung Scarring Claims 11 Australian Lives Every Day: Landmark Report

Why a Breakthrough Blood Cancer Drug Could be Better for Patients

Researchers Develop Predictive Model for Mass Spectrometry Imaging

OGT Launches First Fusion MRD NGS Panel for AML to Expand Fusion Detection at MRD-Level Sensitivity

PARP1 Disassembles Nucleosomes to Facilitate Essential DNA Damage Repair

Squeezing Cell Nuclei Loosens DNA to Boost CRISPR Reprogramming Efficiency

The Future of Vision Restoration With ReVision Implant

How a Single List Is Changing Visibility for Women in Science

How Avatar Medical's 3D Technology Is Transforming How We Visualize the Human Body

Editorial Focus eBook - Biopharmaceuticals (2nd edition)

Improving Cell Culture Efficiency with Image-Guided Automation

Improving Scalability in Organoid Research

Cosmetic Formulation and Manufacturing

Latest in Genomics